DAVITA INC (DVA)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for DVA
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| DVA | Independent Director; Chair | 68 | ["Advisory Partner with Bain & Company, Inc.","Former Partner with Bain","Leader in building Bain’s healthcare practice","Member of the Board of Directors of several public and private companies in the healthcare sector","Member of the Board of Directors of Bristol Myers Squibb Company","Chair of the Blue Cross Blue Shield of Massachusetts Board of Directors from 2014 to 2019"] | ["Nominating and Governance Committee","Compliance and Quality Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| BMY | Director; Additional Member | 68 | ["Healthcare", "Science/Technology/Innovation", "Financial", "Risk Management", "International"] | ["Compensation and Management Development Committee", "Audit Committee", "Science and Technology Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Phyllis R. Yale , 67, has been an Advisory Partner with Bain & Company, Inc. ( Bain ), a global management consulting firm, since July 2010. Ms. Yale was a Partner with Bain from 1987 to July 2010, and a leader in building Bain s healthcare practice. In her role at Bain, Ms. Yale works with healthcare payors, providers, and medical device companies, and frequently advises the world s leading private equity firms on their investments in the healthcare sector. She has served as a member of the board of directors of several public and private companies in the healthcare sector, and since November 2019 has served as a member of the Board of Directors of Bristol Myers Squibb Company, a global biopharmaceutical company. Ms. Yale previously served as Chair of the Blue Cross Blue Shield of Massachusetts ("BCBS") Board of Directors from 2014 to 2019 and served on the board of BCBS from 2014 through December 2024, and as Chair of the Board of Directors of Kindred Healthcare, Inc. from 2010 to 2018. Ms. Yale has a deep knowledge base in the U.S. healthcare sector and has experience in many aspects of the healthcare industry, including corporate strategies, marketing and cost and quality management, as well as mergers and acquisitions.